Close

U.S. Biotech Crops Alliance letter to the White House on agriculture innovation and trade issues

The U.S. Biotech Crops Alliance greatly appreciates your efforts to elevate the U.S.- China dialogue on agricultural innovation. Your engagement with President Xi Jinping at the 2014 APEC Summit established a strong foundation on which to build a robust, mutually beneficial, long-term dialogue on cooperation as it relates to agricultural innovation, including global food security, climate unpredictability and rural economic growth. In this regard, we ask that practical, trade facilitating measures to ensure increased Chinese access to the products of U.S. agriculture be a priority for your upcoming meeting with President Xi.  

2015 BIO Investor Forum Buzz of BIO Winners Announced

BIO is pleased to announce the winners of the 2015 BIO Investor Forum Buzz of BIO contest, which recognizes highly innovative companies in the biotech sector. The Buzz of BIO at the BIO Investor Forum competition featured 19 nominees pulling in over 3,000 votes. The winners are...

BIO Submits Comments Re: CY 2016 Medicare Physician Fee Schedule Proposed Rule

The Biotechnology Industry Organization (BIO) is pleased to submit comments on the Centers for Medicare and Medicaid Services’ (CMS’s) proposed rule entitled Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 20161 (the “Proposed Rule”).

BIO Announces San Diego to Host the World’s Largest Industrial Biotechnology Conference in 2016

BIO officially announced that the 2016 World Congress on Industrial Biotechnology will be held April 17-20, 2016 in San Diego, California at the San Diego Convention Center. BIO is also announcing the call for papers for the event. Leaders from the biotechnology, bioenergy, chemical, consumer products manufacturing, and agricultural industries as well as academia and financial sectors are invited to submit proposals and individual papers beginning September 17, 2015.

Multi-state food and ag organization letter to the White House on agriculture innovation and trade issues

Now more than ever, American agriculture needs your continued engagement with China’s President Xi Jinping on agricultural innovation and trade. The undersigned organizations embrace innovation to continue reliably supplying our valued customers in China and in other markets around the world. Sustainably meeting the challenges of global food security is important not only for China, but for all countries, and requires access to innovation and to markets. For these reasons, we ask you to make securing positive action on pending biotechnology issues a priority when you meet with President Xi in Washington, D.C. later this month. 

Kyle Bass Continues Abuse of Patent Challenge System

The Biotechnology Industry Organization (BIO) today released the following statement regarding the recent IPR challenges filed by hedge fund manager Kyle Bass.

BIO Announces Presenting Companies for 14th Annual BIO Investor Forum

BIO announced the initial list of presenting companies for the 14th Annual BIO Investor Forum, an international investor forum which explores investment trends and opportunities in life sciences. The event focuses on early and mid-stage private as well as emerging public companies that are poised for growth in 2016. The event will take place October 20-21, 2015, at the Parc 55 in San Francisco, California.

BIO Submits Comments Re: CY 2016 Medicare Outpatient Prospective Payment System (OPPS) Proposed Rule

Dear Acting Administrator Slavitt: The Biotechnology Industry Organization (BIO) is pleased to comment on the Centers for Medicare & Medicaid Services (CMS) proposed rule regarding payment policies under the calendar year (CY) 2016 hospital outpatient prospective payment system (OPPS), published in the Federal Register on July 8, 2015 (the “Proposed Rule”).  

Brief of the Biotechnology Industry Organization as Amicus Curiae supporting neither party in Rapid Litigation Management Ltd.v. Cellzdirect Inc. (Appeal from the US District Court for the Northern District of Illinois)

...

Brief of the Biotechnology Industry Organization as Amicus Curiae supporting neither party in Rapid Litigation Management Ltd.v. Cellzdirect Inc. (Appeal from the US District Court for the Northern District of Illinois)

...